These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 32720668)
41. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653 [TBL] [Abstract][Full Text] [Related]
42. New Advances in In Vivo Applications of Gated Mesoporous Silica as Drug Delivery Nanocarriers. García-Fernández A; Aznar E; Martínez-Máñez R; Sancenón F Small; 2020 Jan; 16(3):e1902242. PubMed ID: 31846230 [TBL] [Abstract][Full Text] [Related]
43. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules. Kim TW; Slowing II; Chung PW; Lin VS ACS Nano; 2011 Jan; 5(1):360-6. PubMed ID: 21162552 [TBL] [Abstract][Full Text] [Related]
44. N-Doped graphene quantum dot@mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery. Gui W; Zhang J; Chen X; Yu D; Ma Q Mikrochim Acta; 2017 Dec; 185(1):66. PubMed ID: 29594582 [TBL] [Abstract][Full Text] [Related]
45. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. Gary-Bobo M; Hocine O; Brevet D; Maynadier M; Raehm L; Richeter S; Charasson V; Loock B; Morère A; Maillard P; Garcia M; Durand JO Int J Pharm; 2012 Feb; 423(2):509-15. PubMed ID: 22178618 [TBL] [Abstract][Full Text] [Related]
46. ϵ-Polylysine-Capped Mesoporous Silica Nanoparticles as Carrier of the C9h Peptide to Induce Apoptosis in Cancer Cells. de la Torre C; Domínguez-Berrocal L; Murguía JR; Marcos MD; Martínez-Máñez R; Bravo J; Sancenón F Chemistry; 2018 Feb; 24(8):1890-1897. PubMed ID: 29193344 [TBL] [Abstract][Full Text] [Related]
47. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery. An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716 [TBL] [Abstract][Full Text] [Related]
48. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research. Pattnaik S; Pathak K Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249 [TBL] [Abstract][Full Text] [Related]
49. Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity. Riva B; Bellini M; Corvi E; Verderio P; Rozek E; Colzani B; Avvakumova S; Radeghieri A; Rizzuto MA; Morasso C; Colombo M; Prosperi D J Colloid Interface Sci; 2018 Jun; 519():18-26. PubMed ID: 29477896 [TBL] [Abstract][Full Text] [Related]
50. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin. Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372 [TBL] [Abstract][Full Text] [Related]
51. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers. Qu Q; Ma X; Zhao Y Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067 [TBL] [Abstract][Full Text] [Related]
52. Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery. Tian Z; Xu Y; Zhu Y Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():452-459. PubMed ID: 27987731 [TBL] [Abstract][Full Text] [Related]
53. Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues. Villegas MR; Baeza A; Vallet-Regí M ACS Appl Mater Interfaces; 2015 Nov; 7(43):24075-81. PubMed ID: 26461206 [TBL] [Abstract][Full Text] [Related]
54. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue. González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714 [TBL] [Abstract][Full Text] [Related]
55. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment. Geng H; Chen W; Xu ZP; Qian G; An J; Zhang H Chemistry; 2017 Aug; 23(45):10878-10885. PubMed ID: 28580592 [TBL] [Abstract][Full Text] [Related]
56. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles. Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086 [TBL] [Abstract][Full Text] [Related]
57. MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression. Pan L; Liu J; He Q; Shi J Adv Mater; 2014 Oct; 26(39):6742-8. PubMed ID: 25159109 [TBL] [Abstract][Full Text] [Related]
58. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application. Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004 [TBL] [Abstract][Full Text] [Related]
59. Pillar[6]arene-valved mesoporous silica nanovehicles for multiresponsive controlled release. Huang X; Du X ACS Appl Mater Interfaces; 2014 Nov; 6(22):20430-6. PubMed ID: 25336021 [TBL] [Abstract][Full Text] [Related]